![Michael Owen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Owen
Directeur/Membre du Conseil chez
SAREUM HOLDINGS PLC
Profil
Dr. Michael J.
Owen is a Chairman at Ossianix, Inc., a Member at European Molecular Biology Organization, a Member at The European Molecular Biology Laboratory and a Senior Independent Director at Avacta Life Sciences Ltd. He is on the Board of Directors at Novalgen Ltd., Sareum Holdings Plc, ReNeuron Ltd., Gammadelta Therapeutics Ltd., Ossianix Uk Ltd., The Club Cricket Organisation Ltd. and Avacta Life Sciences Ltd. Dr. Owen was previously employed as an Independent Non-Executive Director by ReNeuron Group Plc, a Senior Independent Director by Avacta Group Plc, an Independent Director by Zealand Pharma A/S, a Chief Scientific Officer by Kymab Ltd., a Senior VP & Head-Biopharmaceuticals Research by GlaxoSmithKline Plc, a Member by Apollo Therapeutics No.
2 LLP, a Non-Executive Director by BliNK Therapeutics Ltd., and a Non-Executive Director by Istesso Ltd. He also served on the board at BliNK Biomedical SAS and Iksuda Therapeutics Ltd. He received his graduate degree from the University of Oxford and a doctorate degree from the University of Cambridge.
Postes actifs de Michael Owen
| Sociétés | Poste | Début |
|---|---|---|
| SAREUM HOLDINGS PLC | Directeur/Membre du Conseil | 13/11/2018 |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Operates as immuno oncology company | Directeur/Membre du Conseil | 01/01/2023 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Ossianix Uk Ltd. | Directeur/Membre du Conseil | - |
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
The Club Cricket Organisation Ltd. | Directeur/Membre du Conseil | - |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Directeur/Membre du Conseil | 15/08/2016 |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Directeur/Membre du Conseil | 24/07/2000 |
The European Molecular Biology Laboratory
 The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Michael Owen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Owen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Sareum Holdings Plc
 Sareum Holdings Plc MiscellaneousMiscellaneous Operates as a holding company, which engages in the discovery and development of drug candidates for the treatment of cancers & autoimmune diseases | Miscellaneous |
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
ReNeuron Ltd.
ReNeuron Ltd. BiotechnologyHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
The European Molecular Biology Laboratory
The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Molecular Biology Organization | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Provides clinical development services for antibody-drug conjugate | Health Technology |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Develops single domain antibodies | Health Technology |
BliNK Therapeutics Ltd.
 BliNK Therapeutics Ltd. BiotechnologyHealth Technology Produces therapeutic monoclonal antibodies | Health Technology |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics | Health Technology |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Health Technology |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Istesso Ltd.
 Istesso Ltd. BiotechnologyHealth Technology Develops treatments for autoimmunity | Health Technology |
The Club Cricket Organisation Ltd. | |
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Ossianix Uk Ltd. | |
Novalgen Ltd.
Novalgen Ltd. BiotechnologyHealth Technology Operates as immuno oncology company | Health Technology |
